What is Cured?
Founded in 2018, Cured operates at the intersection of healthcare and enterprise software. The company specializes in developing sophisticated solutions designed to streamline communication and engagement between healthcare organizations and their patients. By providing a unified platform that integrates disparate health data, Cured enables providers to deliver more personalized care experiences while optimizing operational workflows.
In an industry often characterized by fragmented legacy systems, Cured distinguishes itself through a focus on interoperability and user-centric design. Its market position is bolstered by a clear value proposition: reducing the administrative burden on health systems while simultaneously improving patient outcomes through better connectivity. As the demand for digital-first healthcare solutions continues to accelerate, Cured remains a critical partner for institutions seeking to modernize their patient engagement strategies.
How much funding has Cured raised?
Cured has raised a total of $67.5M across 2 funding rounds:
Angel/Seed
$2.5M
Series B
$65M
Angel/Seed (2019): $2.5M with participation from Waterline Ventures, Matchstick Ventures, and High Alpha
Series B (2021): $65M led by FundFire, Insight Partners, Ridge Ventures, Bessemer Venture Partners, and Inovia
Key Investors in Cured
Waterline Ventures
Waterline Ventures is an investment firm focused on early growth technology and service-enabled technology companies within the healthcare sector.
Matchstick Ventures
Matchstick Ventures is an early-stage venture fund focused on investing in diverse founders and innovative ideas in the North and Rockies.
High Alpha
High Alpha is a venture firm that creates and funds B2B SaaS companies, partnering with founders to build businesses that reach their full potential.
What's next for Cured?
With the backing of top-tier venture firms, Cured is poised to leverage its recent capital to accelerate product innovation and market penetration. The strategic focus will likely shift toward deepening its integration capabilities with existing electronic health record systems and expanding its AI-driven analytics features. As the company scales, the emphasis will remain on maintaining the high-touch, relationship-driven approach that has defined its growth thus far.
Looking ahead, Cured is expected to prioritize the expansion of its enterprise client base, targeting large-scale health systems that require robust, scalable infrastructure. By focusing on long-term value creation rather than short-term growth metrics, the company is well-equipped to navigate the complexities of the healthcare regulatory environment while continuing to set new standards for patient-provider connectivity.
